Pharmaceutical News and Articles

Dementia Tied To Heart, Metabolic Diseases

THURSDAY, May 29, 2025 Heart disease, strokes and diabetes contribute to many dementia cases in the United States, but the risk is not equal everywhere, a new s

Singing Soothes The Savage Infant, Clinical Trial Says

THURSDAY, May 29, 2025 Singing to your baby can soothe them considerably and improve their overall mood, a new clinical trial shows.Parents given smartphone-bas

Parts of the World Seeing New COVID-19 Variant

Health officials at the World Health Organization are warning of a rise in cases from a new COVID-19 variant.The new variant, NB.1.8.1, has been spotted in the

American College of Obstetricians and Gynecologists, May 16-18

The annual meeting of the American College of Obstetricians and Gynecologists (ACOG) was held from May 16 to 18 in Minneapolis and was attended by more than 4,0

Race, Ethnicity Influence Sodium Sources, Sodium Reduction Behavior

There are similarities and differences in the sources of sodium and sodium reduction behaviors between racial and ethnic groups, according to a study published

FDA Approves Tryptyr (acoltremon) Ophthalmic Solution for the Treatment of Dry Eye Disease

Miley Cyrus Reveals Rare Condition That Shapes Her Signature Voice

WEDNESDAY, May 28, 2025 Singer and actress Miley Cyrus says a rare voice disorder called Reinke s edema is behind her famous raspy voice and also makes singing

RFK Jr. Ends COVID Vaccine Urging for Healthy Kids, Pregnant Women

WEDNESDAY, May 28, 2025 The top U.S. health agency will no longer recommend the COVID-19 vaccine for healthy children and pregnant women. Tuesday s announcement

Shedding Pounds in Middle Age Could Add Years to Your Life, Study Finds

WEDNESDAY, May 28, 2025 Losing just 6.5 of body weight in midlife may lower later risk of disease and premature death, new research shows. Researchers found tha

ASCO: GLP-1 Receptor Agonists May Reduce Risk for Obesity-Related Cancer, All-Cause Death

For adults with diabetes and obesity, glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are associated with a reduced risk for obesity-related cancer compar